Načítá se...
Thyrotoxicosis Associated with Ustekinumab Treatment for Psoriasis
Biologic treatments have revolutionised the management of psoriasis in recent years; however, data on their safety profile in large populations and long-term effects are being gathered on an ongoing basis. Ustekinumab is a monoclonal antibody that targets interleukin-12/23 used in the treatment of m...
Uloženo v:
| Vydáno v: | Case Rep Dermatol Med |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7450299/ https://ncbi.nlm.nih.gov/pubmed/32908719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8868553 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|